Pfizer Stock News

South Korea is in the final stage of signing a contract with US drug giant Pfizer Inc. to get its oral drug for COVID-19, Prime Minister Kim Boo-kyum said Friday. "The government has been discussing a purchasing deal with Pfizer for a volume th

Carson City Health and Human Services Carson City Health and Human Services is providing the Quad-County community with a weekly update for the week starting Dec. 16 and ending Dec. 22, 2021. Quad-County COVID-19 Weekly Updates Stopping Starting the first week of January 2022 CCHHS, will no longer provide weekly COVID-19 updates. The final Weekly Quad-County COVID-19 Update will be issued on December 30, 2021. All information provided in the updates can be found on the Nevada Health Responses Dashboard at https://nvhealthresponse.nv.gov/ CCHHS will provide weekly surveillance reports for the Quad-Counties. Those reports are available on our website at https://gethealthycarsoncity.org/novel-coronavirus-2019/quad-county-covi CCHHS will continue monitoring the situation and will provide updates as necessary. COVID-19 Case Update For the week, CCHHS is reporting 4 deaths, 203 new cases, and 305 additional recoveries of COVID-19 in the Quad-County Region. This brings the total number of cases to 22,262, with 17,383 recoveries and 413 deaths; 4,466 cases remain active.

The "Mad Money" host praised Pfizer, Nvidia and others for helping deliver returns for shareholders in 2021.

Pfizer Inc. (NYSE:PFE) with the stream of -1.41% also noticed, India Artelo Biosciences, Inc. (NASDAQ:ARTL) encountered a rapid change of -0.61% in the last hour of Thursdays trading session. Pfizer The post ATR Oversold/Overbought Signals to Track: Pfizer Inc. (NYSE:PFE), Artelo Biosciences, Inc. (NASDAQ:ARTL) appeared first on Stocks Equity .

PITTSBURGH (KDKA) On Thursday, Mercks COVID-19 pill was issued emergency use authorization by the FDA. On Wednesday, Pfizers COVID-19 pill was authorized. Dr. Marc Itskowitz with Allegheny Health Network said this news is a big deal and will make a big impact to help end this pandemic. It gives us a good treatment option []

COVID-19 vaccination bookings in Western Australia open for five to 11-year-old children this morning, with a smaller dose of Pfizer on offer from February 10.

JOHANNESBURG/LONDON -- Omicron advanced across the world on Thursday, with health experts warning the battle against the COVID-19 variant was far from over despite two drugmakers saying their vaccines protected against it and signs it carries a lower risk of hospitalisation. Coronavirus infections have soared wherever the highly infectious Omicron variant has spread, triggering new restrictions in many countries and record new cases. But in another glimmer of hope two days before Christmas, a U.S. Federal Drug Administration official said that data indicated that both Merck''s and Pfizer''s COVID-19 anti-virals are effective against the coronavirus variant. There were encourag Keep on reading: Vaccines, pills, data offer some Christmas cheer in face of Omicron advance

Adults who have not yet been vaccinated against Covid-19 and who object to using vaccines based on newer mRNA techniques should be given the opportunity to opt for the new vaccine from Novavax, the Dutch Health Council recommended. The mRNA vaccines from Pfizer/BioNTech and Moderna are most frequently used in the Netherlands, and even though mRNA has been developed in human trials over the past decade, some continue to be concerned about rumors claiming the technology affects DNA or causes fertility issues.

Eagle Ridge Investment Management grew its holdings in Pfizer Inc. (NYSE:PFE) by 11.6% in the third quarter, HoldingsChannel reports. The fund owned 28,783 shares of the biopharmaceutical companys stock after buying an additional 2,982 shares during the period. Eagle Ridge Investment Managements holdings in Pfizer were worth $1,238,000 as of its most recent filing with []

Pfizer, Inc. (NYSE: PFE ) announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for use by the U.S. Food and Drug Administration. The Pfizer Analysts: SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer. BofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target. Broad Label, Increased Supply To Give Pfizer Dominant Market Position: Pfizer received the nod for the oral COVID-19 treatment ahead of Merck & Co., Inc. (NYSE: MRK ), which submitted its application for its molnupiravir more than a month ahead of Pfizer, Porges said in a note. The analyst sees the increase in Pfizer''s expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink''s current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said. Revenue contribution will drop to $10 billion in 2024, the analyst said.

The US Food and Drug Administration (FDA) on Thursday authorised Merck''s Covid-19 pill for high risk adults, a day after giving the green light to a similar pill by Pfizer.

Second Royal Caribbean Cruise Ship Suffers COVID Outbreak, Denied Entry To Aruba And Curacao This month, the second Royal Caribbean cruise ship to leave South Florida and the third to leave the US has reported COVID-19 infections among crew members and passengers. According to Miami Herald , at least 55 fully vaccinated crew members and passengers on Royal Caribbean''s Odyssey of the Seas tested positive for COVID on Wednesday. Last Saturday, the cruise ship departed from Fort Lauderdale, Florida, and has since been denied entry to Curacao and Aruba. An alleged guest on the cruise ship tweeted, "I''m stuck on a Covid ridden cruise ship.hearing about it on the news rather than from the captain." @RoyalCaribbean Im stuck on a Covid ridden cruise ship.hearing about it on the news rather than from the captain. Only getting two days reimbursementI think they spelled 100% reimbursement wrong #classaction Erin Heos (@ErinHeos) December 23, 2021 In a separate incident, 48 people aboard a Royal Caribbean Symphony of the Seas, the world''s largest cruise ship, tested positive last Saturday after returning from a week-long cruise.

Wall Street''s main indexes rose solidly for a third straight session on Thursday after more encouraging developments about the impact of the Omicron variant of the coronavirus, lifting the mood ahead of Christmas break. The S&P 500 was near its intraday record high as most sectors gained. Industrials and consumer discretionary were the top-performing sectors, both up about 1.3%. Vaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over. The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities. "There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year," said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.

The decision to grant an emergency use authorisation came a day after the agency gave a green light to a similar but more effective pill developed by Pfizer.

Pfizer Inc (NYSE: Full story available on Benzinga.com